Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Rekha Rana and Anant Mahadevan starrer “Ameena” music launched Entertainment
  • The Rising Dawn – A True Story of Injustice, Survival, and Redemption Lifestyle
  • PE Front Office – A software solution that can power your Alternative Investment Fund ahead Business
  • CR Patil and Rashmi Saboo promote the financial empowerment of 100 girls with Sukanya Samriddhi Yojana accounts Press Release
  • Composer duo Javed-Mohsin brings yet another romantic anthem Kabhii Tumhhe from Shershaah Entertainment
  • Lehar Footwears announced H1FY26 and Q2FY26 results, Reports Strong Revenue and PAT Growth Business
  • Kalamandir Jewellers celebrates the extraordinary success of Suvarna Mahotsav 2.0 Lifestyle
  • Vantage Unveils Copy Trading Upgrade with Adjustable Profit-Sharing Feature Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Make in India- BOOK2RIDE a local transportation app launched on Republic Day to ease out the local commute and mobility issues of India Business
  • Libas Consumer Products Ltd. plans Major Diversification in Hi-growth Innerwear segment Business
  • NSF and IDMA Commit to Enhancing cGMP Framework for India’s Nutraceutical Industry Business
  • Troika Tech Launches AI Election Marketing for State and Local Polls in India Business
  • Cupid Limited Receives In-Principle Board Approval to Set Up FMCG Manufacturing Facility in Saudi Arabia Business
  • Blue Pebble Limited H1 FY25 Results: PAT Soars by 356.27% Business

Recent Posts

  • Skill Education vs Online Programmes: IICS Chairman Shwetanshu Jain Explains Why Practical Learning Matters More
  • Meet INT. (Indus Net Technologies): The Digital Transformation Company Quietly Powering India’s Banks, Insurers, and Pharma Giants
  • Current Infraprojects Limited Reports Strong H2 FY26 Performance with Rs 115.90 Cr Revenue & Rs 10.16 Cr Net Profit
  • Best Crypto Presale: AlphaPepe Defies Market Crash as Smart Money Rotates While 100x Listing Rumors Explode
  • Anlon Technology Solutions Limited Announces H2 FY26 & FY26 Results

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • 10 Dynamic Business Leaders to inspire in 2023 Business
  • Start Your Medical Journey at St. George’s University: Now Accepting Applications for the January 2024 Intake from International Students Education
  • Voler Car Limited Announces Q4 FY26 & FY26 Results: FY26 Revenue Growth Driven by Expanding Employee Transportation Operations Business
  • Emerald Finance’s Net Profit Grows by 120 Percent YoY in H1 FY26 Press Release
  • TiE Pune to help local start-ups go global – Ties up with NTT DATA to select start-ups with potential Technology
  • iKargos.com Doubles Revenue to Rs100 Crore, Defies Funding Winter with Profitable Growth Business
  • Khyatiworks celebrates Indian artistry with its colourful murals and artwork acknowledged by the GOI Press Release
  • MP CR Patil launches Brand Surat logo Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme